down arrow

Vista Pharma.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE427C01021
  • NSEID:
  • BSEID: 524711
INR
12.07
0.57 (4.96%)
BSENSE

Apr 11, 12:05 PM

BSE+NSE Vol: 1.63 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

11.6012.07

52 Week

9.1016.59
Valuation
Technical
Day's Volume

CASH

1.63 k (-65.04%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.02%

Held by 0 DIIs

Promoter

21.19%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

  • Poor long term growth as Net Sales has grown by an annual rate of -21.80% and Operating profit at -191.80% over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -3.51
2

Flat results in Dec 24

3

Stock is technically in a Mildly Bearish range

4

Risky - Negative EBITDA

5

Underperformed the market in the last 1 year

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 45 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

27

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.22

stock-summary
Return on Equity

-8.58%

stock-summary
Price to Book

1.25

Revenue and Profits (1 Year):
Net Sales:
3 Cr
(Quarterly Results - Dec 2024)
Net Profit:
-1 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-5.85%
0%
-5.85%
1 Year
-12.54%
0%
-12.54%
2 Years
25.86%
0%
25.86%
3 Years
17.87%
0%
17.87%
4 Years
22.04%
0%
22.04%
5 Years
117.09%
0%
117.09%

Vista Pharma. for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-21.80%
EBIT Growth (5y)
-191.80%
EBIT to Interest (avg)
-3.51
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.36
Tax Ratio
29.17%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
-5.03%
ROE (avg)
0.89%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
27
Price to Book Value
1.25
EV to EBIT
-14.67
EV to EBITDA
-18.43
EV to Capital Employed
1.21
EV to Sales
5.26
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-15.40%
ROE (Latest)
-8.58%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 4 Schemes (0.02%)

FIIs

Held by 0 FIIs

Promoter with highest holding

Vista Pharmaceuticals Inc (10.69%)

Highest Public shareholder

Murali Meraga (14.62%)

Individual Investors Holdings

34.0%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 2.81% vs 38.33% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -36.08% vs -12.79% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2.56",
          "val2": "2.49",
          "chgp": "2.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.51",
          "val2": "-0.83",
          "chgp": "-81.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.22",
          "val2": "0.25",
          "chgp": "-12.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-1.32",
          "val2": "-0.97",
          "chgp": "-36.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-58.98%",
          "val2": "-33.33%",
          "chgp": "-25.65%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -21.28% vs 0.00% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 38.38% vs -257.83% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4.29",
          "val2": "5.45",
          "chgp": "-21.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.60",
          "val2": "-2.09",
          "chgp": "23.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.54",
          "val2": "0.64",
          "chgp": "-15.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-1.83",
          "val2": "-2.97",
          "chgp": "38.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-37.30%",
          "val2": "-38.35%",
          "chgp": "1.05%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -4.20% vs 0.00% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 31.52% vs -156.98% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6.85",
          "val2": "7.15",
          "chgp": "-4.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-3.11",
          "val2": "-3.84",
          "chgp": "19.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.76",
          "val2": "0.94",
          "chgp": "-19.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-3.15",
          "val2": "-4.60",
          "chgp": "31.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-45.40%",
          "val2": "-53.71%",
          "chgp": "8.31%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 929.00% vs 156.41% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 20.32% vs -581.93% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10.29",
          "val2": "1.00",
          "chgp": "929.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-3.57",
          "val2": "-4.45",
          "chgp": "19.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.22",
          "val2": "1.21",
          "chgp": "0.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-4.51",
          "val2": "-5.66",
          "chgp": "20.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-34.69%",
          "val2": "-445.00%",
          "chgp": "410.31%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
2.56
2.49
2.81%
Operating Profit (PBDIT) excl Other Income
-1.51
-0.83
-81.93%
Interest
0.22
0.25
-12.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
-1.32
-0.97
-36.08%
Operating Profit Margin (Excl OI)
-58.98%
-33.33%
-25.65%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 2.81% vs 38.33% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is -36.08% vs -12.79% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
4.29
5.45
-21.28%
Operating Profit (PBDIT) excl Other Income
-1.60
-2.09
23.44%
Interest
0.54
0.64
-15.62%
Exceptional Items
0.00
0.00
Standalone Net Profit
-1.83
-2.97
38.38%
Operating Profit Margin (Excl OI)
-37.30%
-38.35%
1.05%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -21.28% vs 0.00% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is 38.38% vs -257.83% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
6.85
7.15
-4.20%
Operating Profit (PBDIT) excl Other Income
-3.11
-3.84
19.01%
Interest
0.76
0.94
-19.15%
Exceptional Items
0.00
0.00
Standalone Net Profit
-3.15
-4.60
31.52%
Operating Profit Margin (Excl OI)
-45.40%
-53.71%
8.31%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -4.20% vs 0.00% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 31.52% vs -156.98% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
10.29
1.00
929.00%
Operating Profit (PBDIT) excl Other Income
-3.57
-4.45
19.78%
Interest
1.22
1.21
0.83%
Exceptional Items
0.00
0.00
Standalone Net Profit
-4.51
-5.66
20.32%
Operating Profit Margin (Excl OI)
-34.69%
-445.00%
410.31%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 929.00% vs 156.41% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 20.32% vs -581.93% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Vista Pharmaceuticals Ltd stock-summary
stock-summary
Vista Pharmaceuticals Ltd
Micro Cap
Pharmaceuticals & Drugs
Vista Pharmaceuticals Limited was incorporated on January 25,1991 with the Registrar of Companies, Andhra Pradesh & has obtained Certificate of Commencement of Business on February 7, 1991. The Company is engaged in the formulation of pharmaceutical products. It offers a range of products mainly into the therapeutic areas of gastrointestinal, pain management and anti-infection, catering to common ailments.
Company Coordinates stock-summary
Company Details
Plot No 10to14 16to20 APIIC, Industrial Estate Chotyal Nalgonda Telangana : 0
stock-summary
Tel: 91-09291015956
stock-summary
http://www.vistapharmaceuticals.com
stock-summary
admin.hyd@vistapharmaceuticals.com
Registrar Details
Aarthi Consultants Pvt Ltd, 1-2-285 , Domalaguda, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."